Consumo de edulcorantes no nutritivos: efectos a nivel celular y metabólico
DOI:
https://doi.org/10.17533/udea.penh.v20n2a06Palabras clave:
edulcorante no nutritivo, edulcorante, toxicidad, efectos adversos, diabetes mellitusResumen
Antecedentes: la función principal de los edulcorantes no nutritivos es proveer al consumidor un producto dulce sin la carga calórica del azúcar. El consumo de edulcorantes no nutritivos se relaciona con alteraciones en el ADN, con apoptosis y con la síntesis de precursores de cáncer. Además, su consumo también se relaciona recientemente con un incremento de tejido adiposo. Objetivo: analizar el efecto de los edulcorantes no nutritivos a largo plazo, evaluando el riesgo de estos compuestos. Materiales y métodos: búsqueda en bases de datos, PubMed, SciELO y Redalyc, y análisis de bibliografía relacionada con efectos tóxicos y metabólicos del consumo de edulcorantes no nutritivos. Resultados: el consumo de estos edulcorantes presentó efectos citotóxicos en diferentes modelos de estudio. Parece existir una relación con el incremento en la síntesis de tejido adiposo, que provoca obesidad y enfermedades derivadas. Los edulcorantes sintéticos fueron los que presentaron más alteraciones citotóxicas, mientras que edulcorantes naturales, a excepción de los esteviósidos, no presentaron efectos adversos. Múltiples investigaciones explican el efecto del consumo de estos edulcorantes en el metabolismo y los efectos citotóxicos. Conclusiones: el tema de edulcorantes es controversial, por ello la información recopilada en esta revisión busca proporcionar un panorama que ayude a comprender la respuesta a nivel celular y metabólico sobre su consumo.
Descargas
Citas
Johnson RJ, Sánchez-Lozada LG, Andrews P, Lanaspa MA. Perspective: A Historical and scientific perspective of sugar and its relation with obesity and iabetes. Adv Nutr An Int Rev J. 2017;8(3):412-22. DOI: 10.3945/an.116.014654
Rodríguez-Burelo M del R, Avalos-García MI, López-Ramón C. Consumo de bebidas de alto contenido calórico en México: un reto para la salud pública. Salud en Tabasco. 2014;20(1):28-33.
Caravalí-Meza N, Jiménez-Cruz A, Bacardí-Gascón M, Gómez-Miranda LM. Alto riesgo para la salud debido al consumo de bebidas y obesidad entre bachilleres de México. Nutr Hosp. 2015;31(5):2324-6. DOI: 10.3305/nh.2015.31.5.8729
Durán S, Cordón K, Rodríguez M del P. Edulcorantes no nutritivos, riesgos, apetito y ganancia de peso. Rev Chil Nutr. 2013;40(3):309-14. DOI: 10.4067/S0717-75182013000300014
Priya K, Mohan-Gupta VR, Srikanth K. Natural sweeteners: A complete review (PDF Download Available). J Pharm Res. 2011;4(7):2034-9.
Gardner C, Wylie-Rosett J, Gidding SS, Steffen LM, Johnson RK, Reader D, et al. Nonnutritive Sweeteners: Current Use and Health Perspectives: A Scientific Statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2012;35(8):1798-808. DOI: 10.2337/dc12-9002
García-Almeida JM, Ma Casado Fdez G, García Alemán J. Una visión global y actual de los edulcorantes. Aspectos de regulación. Nutr Hosp. 2013;28(4):17-31.
Mattes RD, Popkin BM. Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms 1-3. Am J Clin Nutr. 2009;89:1-14. DOI: 10.3945/ajcn.2008.26792
Fu L, Yang F, Liu X, Wang L, Chen B, Li L, et al. Cucurbitane glycosides from the fruit of Siraitia grosvenori and their effects on glucose uptake in human HepG2 cells in vitro. Food Chem. 2017;228:567-73. DOI: 10.1016/j.foodchem.2017.02.018
Alonso JR. Edulcorantes Naturales. La Granja Rev Ciencias la Vida. 2010;12(2):3-12.
Palacio-Vásquez E, Hurtado-Ibarbo J, Arroyave-Roa JD, Cardona-Caicedo M, Martínez-Girón J. Edulcorantes naturales utilizados en la elaboracion de chocolate. Biotecnol en el Sect Agropecu y Agroindustrial. 2017;15(2):142-52. DOI: 10.18684/BSAA(15)142-152
OMS, FAO. Norma general para los aditivos alimentarios. CODEX STAN 192-1995. Codex Aliment; 2016.
Official Journal of the European Union. Regulaction (EC) No 1333/2008 on food additives; 2008. [Internet]. [Citado julio de 2018]. Disponible en:
https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/uri=CELEX:32008R1333&from=EN
Brusick DJ. A critical review of the genetic toxicity of steviol and steviol glycosides. Food Chem Toxicol. 2008;46(7):S83‑91. DOI: 10.1016/j.fct.2008.05.002
Soffritti M, Belpoggi F, Degli-Esposti D, Lambertini L, tibaldi E, Rigano A. First Experimental Demonstration of the Multipotential Carcinogenic Effects of Aspartame Administered in the Feed to Sprague-Dawley Rats. Environ Health Perspect. 2006;114(3):379-85. DOI: 10.1289/ehp.8711
Schiffman SS, Abou-Donia MB. Sucralose revisited: Rebuttal of two papers about Splenda safety. Vol. 63, Regulatory Toxicology and Pharmacology. 012;63(3):505-8. DOI: 10.1016/j.yrtph.2012.05.002
Bandyopadhyay A, Ghoshal S, Mukherjee A. Genotoxicity Testing of Low-Calorie Sweeteners: Aspartame, Acesulfame-K, and Saccharin. Drug Chem Toxicol. 2008;31(4):447-57. DOI: 10.1080/01480540802390270
Whitehouse CR, Boullata J, McCauley LA.The potential toxicity of artificial sweeteners. AAOHN J. 2008;56(6):251-9.
Ashok I, Sheeladevi R. Biochemical responses and mitochondrial mediated activation of apoptosis on long-term effect of aspartame in rat brain. Redox Biol. 2014;2:820-31. DOI: 10.1016/j.redox.2014.04.011
Ashok I, Sheeladevi R. Oxidant stress evoked damage in rat hepatocyte leading to triggered nitric oxide synthase (NOS) levels on long term consumption of aspartame. J Food Drug Anal. 2015;23(4):679-91. DOI: 10.1016/J.JFDA.2014.07.011
Lohner S, Toews I, Meerpohl JJ. Health outcomes of non-nutritive sweeteners: Analysis of the research landscape. Nutr J. 2017;16(1):1-21. DOI: 10.1186/s12937-017-0278-x
Marinovich M, Galli CL, Bosetti C, Gallus S, La Vecchia C. Aspartame, low-calorie sweeteners and disease: Regulatory safety and epidemiological issues. Food Chem Toxicol. octubre de 2013;60:109-15. DOI: 10.1016/j.fct.2013.07.040
Cernuda-Martínez JA, Fernández-García A. Los edulcorantes y su papel sobre el metabolismo humano. RqR. 2016;4(2):13‑22.
Weihrauch MR, Diehl V. Artificial sweeteners - Do they bear a carcinogenic risk? Ann Oncol. 2004;15(10):1460-5. DOI: 10.1093/annonc/mdh256
Calzada-León R, Ruiz-Reyes ML, Altamirano-Bustamante N, Padrón-Martínez MM. Características de los edulcorantes no calóricos y su uso en niños. Acta Pediatr Mex. 2013;34(3):141-53.
Aguilar J. Edulcorantes artificiales. Revista del consumidor. 2004;58-61.
Zeynep F, Sifa T. Determination of the effects of some artificial sweeteners on human peripheral lymphocytes using the comet assay. J Toxicol Environ Heal Sci. 2014;6(8):147-53. DOI: 10.5897/JTEHS2014.0313
Sasaki YF, Kawaguchi S, Kamaya A, Ohshita M, Kabasawa K, Iwama K, et al. The comet assay with 8 mouse organs: results with 39 currently used food additives. Mutat Res Toxicol Environ Mutagen. 2002;519(1-2):103-19. DOI: 10.1016/S1383-5718(02)00128-6
van Eyk AD. The effect of five artificial sweeteners on Caco-2, HT-29 and HEK-293 cells. Drug Chem Toxicol. 2015;38(3):318‑27. DOI: 10.3109/01480545.2014.966381
Qurrat-ul A, Khan SA. Artificial sweeteners: safe or unsafe? Recent Adv Endocrinol. 2015;65(2):225-7.
Tripathy NK, Mishra R, Anandkumar A, Sahu GP. Lack of genotoxicity of saccharin and sodium saccharin studied in the Drosophyla wing spot and sex-linked recessive lethal tests. Rev Int Contam Ambient. 1994;10(2):89-98.
Jo JH, Kim S, Jeon TW, Jeong TC, Lee S. Investigation of the Regulatory Effects of Saccharin on Cytochrome P450s in Male ICR Mice. Toxicol Res. 2017;33(1):25-30. DOI: 10.5487/TR.2017.33.1.025
Choudhary AK, Pretorius E. Revisiting the safety of aspartame. Nutr Rev. 2017;75(9):718-30. DOI: 10.1093/nutrit/nux035
Belmont-MArtinez L, Fernandez-Lainez C, Ibarra-Gonzalez I, Guillen-López S, Monroy.Santoyo S, Vela-Amieva M. Evaluacion bioquimica de la fenilcetonuria (PKU): del diagnostico al tratamiento. Acta Pediátrica México. 2012;33(6):296-300.
Abdel-Salam OM, Salem NA, El-Shamarka ME, Hussein JS, Ahmed NA, El-Nagar ME. Studies on the effects of aspartame on memory and oxidative stress in brain of mice. Eur Rev Med Pharmacol Sci. 2012;16(15):2092-101.
Rycerz K, Jaworska-Adamu JE. Effects of aspartame metabolites on astrocytes and neurons. Folia Neuropathol. 2013;51(1):10-7. DOI: 10.5114/fn.2013.34191
Villareal LMA, Cruz RAM, Ples MB, Vitor RJS. Neurotropic effects of aspartame, stevia and sucralose on memory retention and on the histology of the hippocampus of the ICR mice (Mus musculus). Asian Pac J Trop Biomed. 2016;6(2):114-8. DOI: 10.1016/j.apjtb.2015.11.001
Ciappuccini R, Ansemant T, Maillefert J-F, Tavernier C, Ornetti P. Aspartame-induced fibromyalgia, an unusual but curable cause of chronic pain. Clin Exp Rheumatol. 2010;28(6 Suppl 63):S131-3.
Demir E, Turna F, Aksakal S, Kaya B, Marcos R. Genotoxicity of different sweeteners in Drosophila. Fresenius Environ Bull. 2014;23(12C):3426-32.
Zafar T, Naik AB Q, Srivastavam V. Aspartame : Effects and Awareness. MOJ Toxicol. 2017;3(2):1-5. DOI: 10.15406/mojt.2017.03.00046
Rodero AB, Rodero LDS, Azoubel R. Toxicity of Sucralose in Humans: A Review. Int J Morphol. 2009;27(1):239-44. DOI: 10.4067/S0717-95022009000100040
Brusick D, Borzelleca JF, Gallo M, Williams G, Kille J, Wallace-Hayes A, et al. Expert Panel report on a study of Splenda in male rats. Regul Toxicol Pharmacol. 2009;55(1):6-12. DOI: 10.1016/j.yrtph.2009.06.013
Grotz VL, Munro IC. An overview of the safety of sucralose. Regul Toxicol Pharmacol. 2009;55:1-5. DOI: 10.1016/j.yrtph.2009.05.011
Bian X, Chi L, Gao B, Tu P, Ru H, Lu K. Gut microbiome response to sucralose and its potential role in inducing liver inflammation in mice. Front Physiol. 2017;8:487. DOI: 10.3389/fphys.2017.00487
Bigal ME. The association between migraine and obesity: Empty calories? Cephalalgia. 2012;32(13):950-2. DOI: 10.1177/0333102412455715
Bigal ME, Krymchantowski A V. Migraine Triggered by Sucralose - A Case Report. Headache. 2006;46(3):515-7. DOI: 10.1111/j.1526-4610.2006.00386_1.x
Patel RM, Sarma R, Grimsley E. Popular sweetner sucralose as a migraine trigger. Headache. 2006;46(8):1303-4. DOI: 10.1111/j.1526-4610.2006.00543_1.x
Abou-Donia MB, El-Masry EM, Abdel-Rahman AA, McLendon RE, Schiffman SS. Splenda Alters Gut Microflora and Increases Intestinal P-Glycoprotein and Cytochrome P-450 in Male Rats. J Toxicol Environ Health. 2008;71(21):1415-29. DOI: 10.1080/15287390802328630
Tovar A, Navalta J, Kruskall L, Young J. The effect of moderate consumption of non-nutritive sweeteners on glucose tolerance and body composition in rats. Appl Physiol Nutr Metab. 2016;42(11):1225-7. DOI: 10.1139/apnm-2017-0120
Magnuson BA, Roberts A, Nestmann ER. Critical review of the current literature on the safety of sucralose. Food Chem Toxicol. 2017;106(Pt A):324-55. DOI: 10.1016/j.fct.2017.05.047
Sylvetsky AC, Bauman V, Blau JE, Garraffo HM, Walter PJ, Rother KI. Plasma concentrations of sucralose in children and adults. Toxicol Environ Chem. 2017;99(3):535-42. DOI: 10.1080/02772248.2016.1234754
Gupta E, Purwar S, Sundaram S, Rai GK. Nutritional and therapeutic values of Stevia rebaudiana : A review. J Med Plant Res. 2013;7(46):3343-53. DOI: 10.5897/JMPR2013.5276
GSI. Glosario de Términos relacionados con la Stevia. Global Stevia Institute; 2017. [Internet]. [Citado febrero de 2018]. Disponible en:
Ren H-P, Yin X-Y, Yu H-Y, Xiao H-F. Stevioside induced cytotoxicity in colon cancer cells via reactive oxygen species and mitogen-activated protein kinase signaling pathways-mediated apoptosis. Oncol Lett. 2017;13(4):2337-43. DOI: 10.3892/ ol.2017.5744
Pallarés Á, Carrasco G, Nava Y, Pallarés O, Pérez I, Rifá R, et al. Effectiveness and safety of Stevia rebaudiana dried leaves as an adjuvant in the short-term treatment of type 2 diabetes: A randomized, controlled, cross-over and double-blinded trial. JMPHTR. 2015;3:16-26.
Ruiz-Ruiz JC, Moguel-Ordoñez YB, Segura-Campos MR. Biological activity of Stevia rebaudiana Bertoni and their relationship to health. Crit Rev Food Sci Nutr. 2017;57(12):2680-90. DOI: 10.1080/10408398.2015.1072083
Sámano-Salazar C, Alemón-Medina R, Chávez-Pacheco JL, Dávila-Borja VM. Citotoxicidad de los edulcorantes Splenda® y Svetia® en formulaciones extemporáneas pediátricas. Acta Pediátr Méx. 2015;36(1):3-8.
Mukhtar M, Tiong C, Bukhari S, Abdullah A, Ming L. Safety and efficacy of health supplement (Stevia rebaudiana). Arch Pharm Pract. 2016;7(5):16. DOI: 10.4103/2045-080X.183032
Lemus-Mondaca R, Vega-Gálvez A, Zura-Bravo L, Kong AH. Stevia rebaudiana Bertoni, source of a high-potency natural sweetener: A comprehensive review on the biochemical, nutritional and functional aspects. Food Chem. 2012;132(3):112132. DOI: 10.1016/j.foodchem.2011.11.140
Ashwell M. Stevia, Nature’s Zero-Calorie Sustainable Sweetener A New Player in the Fight Against Obesity. Nutr Today. 2015;50(3):129-34. DOI: 10.1097/NT.0000000000000094
López-Díaz MT, Medán-Robledo E. De la stevia al E-960: un dulce camino. REDUCA. 2014;6(1):305-11.
FDA. FDA Basics - Has Stevia been approved by FDA to be used as a sweetener? U.S Food & Drug Administration. Office of the Commissioner; 2018. [Internet]. [Citado julio de 2018]. Disponible en https://www.fda.gov/aboutfda/transparency/basics/ucm194320.htm
Itkin M, Davidovich-Rikanati R, Cohen S, Portnoy V, Doron-Faigenboim A, Oren E, et al. The biosynthetic pathway of the nonsugar, high-intensity sweetener mogroside V from Siraitia grosvenorii. Proc Natl Acad Sci. 2016;113(47):E7619-28. DOI: 10.1073/pnas.1604828113
Tao L, Yang J, Cao F, Xie H, Zhang M, Gong Y, et al. Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways. J Pharmacol Exp Ther. 2017;361(2):268-79. DOI: 10.1124/jpet.116.239137
Cao F, Zhang Y, Li W, Shimizu K, Xie H, Zhang C. Mogroside IVE attenuates experimental liver fibrosis in mice and inhibits HSC activation through downregulating TLR4-mediated pathways. Int Immunopharmacol. 2018;55:183-92. DOI: 10.1016/j.intimp.2017.12.023
Qin X, Xiaojian S, Ronggan L, Yuxian W, Zhunian T, Shouji G, et al. Subchronic 90-day oral (Gavage) toxicity study of a Luo Han Guo mogroside extract in dogs. Food Chem Toxicol. 2006;44(12):2106-9. DOI: 10.1016/j.fct.2006.07.023
Jin M, Muguruma M, Moto M, Okamura M, Kashida Y, Mitsumori K. Thirteen-week repeated dose toxicity of Siraitia grosvenori extract in Wistar Hannover (GALAS) rats. Food Chem Toxicol. 2007;45(7):1231-7. DOI: 10.1016/j.fct.2006.12.030
Luo Z, Qiu F, Zhang K, Qin X, Guo Y, Shi H, et al. In vitro AMPK activating effect and in vivo pharmacokinetics of mogroside V, a cucurbitane-type triterpenoid from Siraitia grosvenorii fruits. RSC Adv. 2016;6(9):7034-41. DOI: 10.1039/C5RA23275A
Cho S. Determinatios of the generally recognized as safe (GRAS) status of Luo Han Guo extracts as a food ingredient. 2014. [Internet]. [Citado marzo de 2018]. Disponible en:
https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm505159.pdf
Pijoan M. Los dulces de un mundo sin azúcar. Offarm. 2006;25(5):102-10.
Aidoo RP, Afoakwa EO, Dewettinck K. Rheological properties, melting behaviours and physical quality characteristics of sugar-free chocolates processed using inulin/polydextrose bulking mixtures sweetened with stevia and thaumatin extracts. Food Sci Technol. 2015;62(1):592-7. DOI: 10.1016/j.lwt.2014.08.043
Grembecka M. Natural sweeteners in a human diet. Rocz Państwowego Zakładu Hig. 2015;66(3):195-202.
Haider P. Wonderful Thaumatin Sweetener from Katemfe Fruit Relax Into Success; 2015. [Internet Blog]. [Citado febrero de 2018]. Disponible en
https://paulhaider.wordpress.com/2015/06/29/wonderful-thaumatin-sweetener-from-katemfe-fruit/
Angarita L, Agüero DS, Villasmil RN, Miranda Rol de la LJ, Angarita L, Durán Agüero S,Angarita Dávila L, Durán Agüero S, Apaicio D, Parra K, Uzcátegui M, Céspedes V, et al. Rol de la estevia y L-carnitina sobre el impacto glicémico de un suplemento nutricional en adultos. Nutr Hosp. 2017;34(5):1455-62. DOI: 10.20960/nh.1153
International Diabetes Federation. The IDF Diabetes Atlas Mexico. The IDF Diabetes Atlas 8th Edition 2017. 2017. [Internet]. [Citado febrero de 2018]. Disponible en: https://reports.instantatlas.com/report/view/704ee0e6475b4af885051bcec15f0e2c
OMS. Informe mundial sobre la diabetes. 2016. [Internet]. [Citado febrero de 2018]. Disponible en: http://apps.who.int/iris/bitstream/handle/10665/204877/WHO_NMH_NVI_16.3_spa.pdf;jsessionid=D4700A2D383B690D0035DAF30FD760E8?sequence=1
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-20. DOI: 10.1038/414813a
Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes. 2008;26(2):77-82. DOI: 10.2337/diaclin.26.2.77
Bolaños-Rios P. Alimentación y riesgo de enfermar. Trastor la Conduct Aliment. 2011;14:1550-84.
Brown RJ, De Banate MA, Rother KI. Artificial Sweeteners: A systematic review of metabolic effects in youth. Int J Pediatr Obes. 2010;5(4):305-12. DOI: 10.3109/17477160903497027
Burke M V, Small DM. Physiological mechanisms by which non-nutritive sweeteners may impact body weight and metabolism. Physiol Behav. 2015;152(Pt B):381-8. DOI: 10.1016/j.physbeh.2015.05.036
Simon BR, Parlee SD, Learman BS, Mori H, Scheller EL, Cawthorn WP, et al. Artificial sweeteners stimulate adipogenesis and suppress lipolysis independently of sweet taste receptors. J Biol Chem. 2013;288(45):32475-89. DOI: 10.1074/jbc.M113.514034
Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. 2014;514(7521):181-6. DOI: 10.1038/nature13793
Yang Q. Gain weight by “going diet?” Artificial sweeteners and the neurobiology of sugar cravings. Yale J Biol Med. 2010;83(2):101-8. DOI: 10.1161/CIRCULATIONAHA.109.876185.Sugar
Angarita Dávila LC, López Miranda J, Aparicio Camargo D, Parra Zuleta K, Uzcátegui González M, Céspedes Nava V, et al. Índice glicémico, carga glicémica e insulina posprandial a dos fórmulas isoglucídicas con distintos edulcorantes y fibra en adultos sanos y diabéticos tipo 2. Nutr Hosp. 2017;34(3):532-9. DOI: 10.20960/nh.654
Pepino M, Tiemann C, Patterson B, Wice B, Klein S. Sucralose affects glycemic and hormonal responses to an oral glucose load. Diabetes Care. 2013;36(9):2530-5. DOI: 10.2337/dc12-2221
Swithers SE, Martin AA, Davidson TL. High-intensity sweeteners and energy balance. Physiol Behav. 2010;100(1):55-62. DOI: 10.1016/j.physbeh.2009.12.021
Fernstrom JD, Munger SD, Sclafani A, de Araujo IE, Roberts A, Molinary S. Mechanisms for Sweetness. J Nutr. 2012;142(6):1134S-41S. DOI: 10.3945/jn.111.149567
DuBois GE. Molecular mechanism of sweetness sensation. Physiol and Behav. 2016;164(Pt B):453-63. DOI: 10.1016/j.physbeh.2016.03.015
Beauchamp GK. Why do we like sweet taste: A bitter tale?. Physiol Behav. 2016;164(Pt B):432-7. DOI: 10.1016/j.physbeh.2016.05.007
Olsen NJ, Heitmann BL. Intake of calorically sweetened beverages and obesity. Obes Rev. 2009;10(1):68-75. DOI: 10.1111/j.1467-789X.2008.00523.x
Choudhary AK. Aspartame: should individuals with Type II Diabetes be taking it? Curr Diabetes Rev. 2018;14(4):350-62. DOI: 10.2174/1573399813666170601093336
Mooradian AD, Smith M, Tokuda M. The role of artificial and natural sweeteners in reducing the consumption of table sugar: A narrative review. Clin Nutr ESPEN. 2017;18:1-8. DOI: 10.1016/j.clnesp.2017.01.004
Fagherazzi G, Vilier A, Sartorelli DS, Lajous M, Balkau B, Clavel-Chapelon F. Consumption of artificially and sugarsweetened beverages and incident type 2 diabetes in the Etude Epidé miologique auprè s des femmes de la Mutuelle Gé né rale de l’Education Nationale-European Prospective Investigation into Cancer and Nutrition cohort1. Am J Clin Nutr. 2013;97(3):517‑23. DOI: 10.3945/ajcn.112.050997
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2024 Universidad de Antioquia
